MLYS Scorecard | MINERALYS THERAPEUTICS, INC.

MINERALYS THERAPEUTICS, INC. (MLYS) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

7/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q20/3	LoseMLYS / S&P -0.41% / 15.20%	LoseMLYS / S&P MLYS unavailable / 15.00%	LoseMLYS / S&P 17.70% / 50.40%
2026-Q10/3	LoseMLYS / S&P -25.35% / -4.33%	LoseMLYS / S&P MLYS unavailable / 11.30%	LoseMLYS / S&P -46.38% / 27.70%
2025-Q40/3	LoseMLYS / S&P -4.30% / 2.65%	LoseMLYS / S&P MLYS unavailable / 9.00%	LoseMLYS / S&P -36.26% / 13.40%
2025-Q31/3	WinMLYS / S&P 180.27% / 8.12%	LoseMLYS / S&P MLYS unavailable / 4.61%	LoseMLYS / S&P -10.33% / 13.45%
2025-Q21/3	LoseMLYS / S&P -14.80% / 10.94%	LoseMLYS / S&P MLYS unavailable / 4.83%	WinMLYS / S&P 30.40% / 10.63%
2025-Q12/3	WinMLYS / S&P 29.00% / -4.27%	LoseMLYS / S&P MLYS unavailable / 4.98%	WinMLYS / S&P 68.78% / 10.57%
2024-Q41/3	LoseMLYS / S&P 1.65% / 2.41%	LoseMLYS / S&P MLYS unavailable / 5.25%	WinMLYS / S&P 80.20% / 6.15%
2024-Q30/3	LoseMLYS / S&P 3.50% / 5.89%	LoseMLYS / S&P MLYS unavailable / 5.89%	LoseMLYS / S&P 4.78% / 6.11%
2024-Q20/3	LoseMLYS / S&P -9.37% / 4.28%	LoseMLYS / S&P MLYS unavailable / 5.38%	LoseMLYS / S&P -29.27% / 5.12%
2024-Q11/3	WinMLYS / S&P 50.12% / 10.56%	LoseMLYS / S&P MLYS unavailable / 5.71%	LoseMLYS / S&P -54.05% / 5.59%
2023-Q40/3	LoseMLYS / S&P -9.57% / 11.69%	LoseMLYS / S&P MLYS unavailable / 6.81%	LoseMLYS / S&P -65.05% / 7.78%
2023-Q30/3	LoseMLYS / S&P -44.22% / -3.27%	LoseMLYS / S&P MLYS unavailable / 7.52%	LoseMLYS / S&P MLYS unavailable / -5.03%
2023-Q21/3	WinMLYS / S&P 8.88% / 8.74%	LoseMLYS / S&P MLYS unavailable / 9.50%	LoseMLYS / S&P MLYS unavailable / -8.57%
2023-Q10/3	LoseMLYS / S&P MLYS unavailable / 7.50%	LoseMLYS / S&P MLYS unavailable / 10.77%	LoseMLYS / S&P MLYS unavailable / -15.69%
2022-Q40/3	LoseMLYS / S&P MLYS unavailable / 7.56%	LoseMLYS / S&P MLYS unavailable / 11.88%	LoseMLYS / S&P MLYS unavailable / -17.99%
2022-Q30/3	LoseMLYS / S&P MLYS unavailable / -4.88%	LoseMLYS / S&P MLYS unavailable / 13.47%	LoseMLYS / S&P MLYS unavailable / -1.41%
2022-Q20/3	LoseMLYS / S&P MLYS unavailable / -16.10%	LoseMLYS / S&P MLYS unavailable / 13.71%	LoseMLYS / S&P MLYS unavailable / 11.04%
2022-Q10/3	LoseMLYS / S&P MLYS unavailable / -4.60%	LoseMLYS / S&P MLYS unavailable / 15.97%	LoseMLYS / S&P MLYS unavailable / 42.23%
2021-Q40/3	LoseMLYS / S&P MLYS unavailable / 11.03%	LoseMLYS / S&P MLYS unavailable / 15.00%	LoseMLYS / S&P MLYS unavailable / 96.40%
2021-Q30/3	LoseMLYS / S&P MLYS unavailable / 0.58%	LoseMLYS / S&P MLYS unavailable / 10.77%	LoseMLYS / S&P MLYS unavailable / 69.42%
2021-Q20/3	LoseMLYS / S&P MLYS unavailable / 8.55%	LoseMLYS / S&P MLYS unavailable / 6.58%	LoseMLYS / S&P MLYS unavailable / 51.81%
2021-Q10/3	LoseMLYS / S&P MLYS unavailable / 6.17%	LoseMLYS / S&P MLYS unavailable / -1.06%	LoseMLYS / S&P MLYS unavailable / 7.39%
2020-Q40/3	LoseMLYS / S&P MLYS unavailable / 12.15%	LoseMLYS / S&P MLYS unavailable / -3.72%	LoseMLYS / S&P MLYS unavailable / -33.42%
2020-Q30/3	LoseMLYS / S&P MLYS unavailable / 8.93%	LoseMLYS / S&P MLYS unavailable / -2.04%	LoseMLYS / S&P MLYS unavailable / -27.10%
2020-Q20/3	LoseMLYS / S&P MLYS unavailable / 20.54%	LoseMLYS / S&P MLYS unavailable / -0.46%	LoseMLYS / S&P MLYS unavailable / -27.11%
2020-Q10/3	LoseMLYS / S&P MLYS unavailable / -19.60%	LoseMLYS / S&P MLYS unavailable / 3.47%	LoseMLYS / S&P MLYS unavailable / -14.75%
2019-Q40/3	LoseMLYS / S&P MLYS unavailable / 9.07%	LoseMLYS / S&P MLYS unavailable / 5.36%	LoseMLYS / S&P MLYS unavailable / 2.99%
2019-Q30/3	LoseMLYS / S&P MLYS unavailable / 1.70%	LoseMLYS / S&P MLYS unavailable / 5.02%	LoseMLYS / S&P MLYS unavailable / 0.21%
2019-Q20/3	LoseMLYS / S&P MLYS unavailable / 4.30%	LoseMLYS / S&P MLYS unavailable / 6.64%	LoseMLYS / S&P MLYS unavailable / 8.65%
2019-Q10/3	LoseMLYS / S&P MLYS unavailable / 13.65%	LoseMLYS / S&P MLYS unavailable / 8.12%	LoseMLYS / S&P MLYS unavailable / 14.29%
2018-Q40/3	LoseMLYS / S&P MLYS unavailable / -13.52%	LoseMLYS / S&P MLYS unavailable / 9.05%	LoseMLYS / S&P MLYS unavailable / 18.23%
2018-Q30/3	LoseMLYS / S&P MLYS unavailable / 7.71%	LoseMLYS / S&P MLYS unavailable / 10.21%	LoseMLYS / S&P MLYS unavailable / 19.06%
2018-Q20/3	LoseMLYS / S&P MLYS unavailable / 3.43%	LoseMLYS / S&P MLYS unavailable / 9.03%	LoseMLYS / S&P MLYS unavailable / 14.46%
2018-Q10/3	LoseMLYS / S&P MLYS unavailable / -0.76%	LoseMLYS / S&P MLYS unavailable / 7.68%	LoseMLYS / S&P MLYS unavailable / 12.46%
2017-Q40/3	LoseMLYS / S&P MLYS unavailable / 6.64%	LoseMLYS / S&P MLYS unavailable / 7.03%	LoseMLYS / S&P MLYS unavailable / 13.82%
2017-Q30/3	LoseMLYS / S&P MLYS unavailable / 4.48%	LoseMLYS / S&P MLYS unavailable / 5.68%	LoseMLYS / S&P MLYS unavailable / 17.57%
2017-Q20/3	LoseMLYS / S&P MLYS unavailable / 3.09%	LoseMLYS / S&P MLYS unavailable / 4.83%	LoseMLYS / S&P MLYS unavailable / 17.74%
2017-Q10/3	LoseMLYS / S&P MLYS unavailable / 6.07%	LoseMLYS / S&P MLYS unavailable / 3.67%	LoseMLYS / S&P MLYS unavailable / 13.32%
2016-Q40/3	LoseMLYS / S&P MLYS unavailable / 3.82%	LoseMLYS / S&P MLYS unavailable / 2.09%	LoseMLYS / S&P MLYS unavailable / 7.05%
2016-Q30/3	LoseMLYS / S&P MLYS unavailable / 3.85%	LoseMLYS / S&P MLYS unavailable / 0.20%	LoseMLYS / S&P MLYS unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	MLYS total return	S&P 500 Total Return Index
Total return	68.02%	20.78%
Annualized return	68.02%	20.78%

5Y · 2023-02-10 to 2026-08-27

Metric	MLYS total return	S&P 500 Total Return Index
Total return	41.05%	83.14%
Annualized return	7.12%	12.86%

10Y · 2023-02-10 to 2026-08-27

Metric	MLYS total return	S&P 500 Total Return Index
Total return	41.05%	319.30%
Annualized return	3.50%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Viridian Therapeutics, Inc.\DE (VRDN)	United States	$2.342B	-5.38
Harmony Biosciences Holdings, Inc. (HRMY)	United States	$2.399B	11.67
Vera Therapeutics, Inc. (VERA)	United States	$2.402B	-7.67
uniQure N.V. (QURE)		$2.416B	-4.93
SELLAS Life Sciences Group, Inc. (SLS)	United States	$2.420B	-91.87
Nurix Therapeutics, Inc. (NRIX)	United States	$2.457B	-5.39
Zai Lab Ltd (ZLAB)		$2.241B	-113.34
Aurinia Pharmaceuticals Inc. (AUPH)		$2.207B	7.18
SUPERNUS PHARMACEUTICALS, INC. (SUPN)	United States	$2.517B	-24.63
Immunome Inc. (IMNM)	United States	$2.538B	-9.45